Generare Bioscience
Generare Bioscience
Generating never-before-seen molecular data for drug development using artificial intelligence.
About
What does Generare Bioscience do?
Generare Bioscience is a biotechnology company focused on generating novel molecular data for drug development. They leverage artificial intelligence to discover and advance new drugs.
What is Generare Bioscience's revenue?
StartupHub estimates Generare Bioscience's annual revenue at $2.8M (range $1.0M to $8.9M, 34% confidence), based on comparable companies in the sector.
What is Generare Bioscience's valuation?
StartupHub estimates Generare Bioscience's effective valuation at $92.3M (range $58.3M to $139.8M, 23% confidence), based on comparable companies in the sector.
How much funding has Generare Bioscience raised?
Generare Bioscience has raised a total of $23M in funding. The most recent round on record is Series A.
Where is Generare Bioscience headquartered?
Generare Bioscience is headquartered in Paris, France.
When was Generare Bioscience founded?
Generare Bioscience was founded in 2023.
What industry does Generare Bioscience operate in?
Generare Bioscience operates in Biotechnology, Drug Discovery, Artificial Intelligence.
No comments yet. Be the first to share your take.